Search results
Results From The WOW.Com Content Network
The shortage means people like Amanda Cella, a 37-year-old South Jersey resident, have to scramble to find a pharmacy that still has the drug in stock. Cella was prescribed Zepbound in February.
April 17, 2024 at 1:51 PM. (Reuters) -Most doses of Eli Lilly's diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to ...
This image provided by Eli Lilly on Wednesday, Nov. 8, 2023 shows packaging for their new drug Zepbound. The new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss ...
A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly, is seen at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023.
February 5, 2024 at 12:52 PM. (Reuters) -The U.S. Food and Drug Administration's (FDA) website showed that three higher doses of Eli Lilly's diabetes drug, Mounjaro, would be available only in ...
On Nov. 8, the Food and Drug Administration approved the drug tirzepatide, sold under the name Zepbound by Eli Lilly, for chronic weight loss management for obese and overweight adults, the agency ...
The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months ...
Prescriptions for Zepbound, which was approved by the U.S. Food and Drug Administration on Nov. 8, can be filled at retail and mail-order pharmacies as of Dec. 5, drug maker Eli Lilly announced.